author-photo

Oliver G. Ottmann

Goethe University Frankfurt
Cardiff University

503

Papers

21883

Citations

Citation Trend

Filter By

Papers (337) Sort By

Journal Conference Others

Adjunctive Volasertib in Patients With Acute Myeloid Leukemia not Eligible for Standard Induction Therapy: A Randomized, Phase 3 Trial

2021
Show All
- Source
- Cite
- Save
Citations (0)
Oncogene-independent resistance in Philadelphia chromosome - positive (Ph+) acute lymphoblastic leukemia (ALL) is mediated by activation of AKT/mTOR pathway.

2021 Neoplasia
Show All
- Source
- Cite
- Save
Citations (0)
MDS-404: Population Pharmacokinetics Modeling and Evaluation of Clinical Efficacy and Safety of Sabatolimab: Dose Selection and Dose-Response Analysis

2021 Clinical Lymphoma, Myeloma & Leukemia
Show All
- Source
- Cite
- Save
Citations (0)
MDS-420: Sabatolimab Plus Hypomethylating Agents (HMAs) in Patients with High-/Very High-risk Myelodysplastic Syndrome (HR/vHR-MDS) and Newly Diagnosed Acute Myeloid Leukemia (ND-AML): Subgroup Analysis of a Phase 1 Study

2021 Clinical Lymphoma, Myeloma & Leukemia
Show All
- Source
- Cite
- Save
Citations (0)
Arsenic Trioxide Suppresses Growth of BCR-ABL1 Positive Cells with Gatekeeper or Compound Mutation

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Tinkering under the Hood: Metabolic Optimisation of CAR-T Cell Therapy.

2021 Antibodies
Show All
- Source
- Cite
- Save
Citations (0)
Efficacy and Safety of Sabatolimab (MBG453) in Combination with Hypomethylating Agents (HMAs) in Patients (Pts) with Very High/High-Risk Myelodysplastic Syndrome (vHR/HR-MDS) and Acute Myeloid Leukemia (AML): Final Analysis from a Phase Ib Study

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
The impact of COVID-19 on cancer care and oncology clinical research: an experts’ perspective

2021
Show All
- Source
- Cite
- Save
Citations (0)
Long-term follow-up of blinatumomab in patients with relapsed/refractory Philadelphia chromosome-positive B-cell precursor acute lymphoblastic leukaemia: Final analysis of ALCANTARA study.

2021 European Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (3)
Correction: Standardisation and consensus guidelines for minimal residual disease assessment in Philadelphia-positive acute lymphoblastic leukemia (Ph+ALL) by real-time quantitative reverse transcriptase PCR of e1a2 BCR-ABL1 (Leukemia, (2019), 33, 8, (1910-1922), 10.1038/s41375-019-0413-0)

2020 Leukemia
Show All
- Source
- Cite
- Save
Citations (0)